Is Hydroxyzine Safe for Long-Term Use?

Hydroxyzine is reasonably safe for short-term use under medical supervision, but the evidence raises genuine concerns about taking it for months or years. As a first-generation antihistamine with strong anticholinergic properties, it carries risks that accumulate over time, including persistent sedation that doesn’t fade, a dose-dependent link to dementia, potential heart-rhythm effects, and specific hazards for older adults, pregnant women, and young children. Whether those risks are acceptable depends on what you’re taking it for, how much you’re taking, and what alternatives exist.

Why People End Up on Hydroxyzine Long-Term

Hydroxyzine was first marketed in the mid-1950s and is prescribed for two broad purposes: managing anxiety (under the brand name Atarax or Vistaril) and controlling itching from conditions like chronic urticaria and eczema. It works by blocking histamine receptors, which reduces allergic symptoms and itching, while also crossing into the brain and producing sedation and anxiolytic effects. Unlike benzodiazepines, hydroxyzine isn’t classified as a controlled substance and doesn’t carry the same regulatory warnings about addiction, which makes some prescribers reach for it more readily for ongoing anxiety.

The trouble is that hydroxyzine was never really designed or studied as a long-term medication. Most clinical trials lasted only a few weeks to a few months. A three-month double-blind trial showed hydroxyzine outperformed placebo for generalized anxiety disorder, with patients on hydroxyzine showing greater reductions in anxiety scores and higher remission rates than those on placebo. But three months is still a short window for a drug that some people take for years.

¹

For chronic itching, a 12-week observational study of nearly 400 patients found that hydroxyzine produced significant relief, with itch scores dropping by about 48% and quality-of-life scores improving by over 90% from baseline. Side effects during that period were mild and uncommon. But observational studies in motivated patients over just 12 weeks don’t tell us much about what happens over the following year or two.

²

The Sedation That Doesn’t Go Away

One of the most common assumptions about hydroxyzine is that the drowsiness wears off after a few days as your body adjusts. This appears to be wrong. A controlled trial comparing hydroxyzine to a second-generation antihistamine found that over five days of hydroxyzine use, neither objective measures of reaction time nor subjective reports of drowsiness showed any development of tolerance.

³

This matters because hydroxyzine has a long half-life of roughly 20 to 25 hours, meaning a dose taken at bedtime is still active well into the next day. Research on sedating antihistamines for chronic hives found that while hydroxyzine taken at night did reduce itching, it increased daytime sleepiness without improving treatment outcomes compared to non-sedating alternatives. The researchers concluded that the sedation spilled over into daytime functioning, reducing alertness and productivity.

⁴

If you’re taking hydroxyzine every day for months, this persistent sedation isn’t just an inconvenience. It can affect your driving, your work performance, and your ability to react quickly in an emergency. And because the drowsiness doesn’t seem to fade with continued use, these impairments are ongoing rather than temporary.

Heart Rhythm and QT Prolongation

In 2015, European regulators issued safety advisories about hydroxyzine and a heart-rhythm abnormality called QT prolongation, which in rare cases can trigger a dangerous irregular heartbeat. This prompted a closer look at the drug’s cardiac profile. Lab studies confirmed that hydroxyzine blocks a specific cardiac ion channel (hERG) in a dose-dependent way, which is a known mechanism for QT prolongation. However, the drug also inhibits other cardiac ion channels, and the net effect on heart rhythm may be partially offset by these competing actions.

⁵

The real-world numbers are reassuring to a point. Over about nine million patient-years of exposure tracked through sales and safety data, only 34 cases of QT prolongation or the dangerous arrhythmia torsade de pointes were reported, working out to roughly four cases per million patient-years. And among patients who were taking the recommended dose or less, every single reported case had at least one other independent risk factor, most commonly an existing heart condition combined with another QT-prolonging medication.

⁵

The practical takeaway: if you have a healthy heart and aren’t taking other medications that affect heart rhythm, the cardiac risk from hydroxyzine at normal doses is very small. But the risk climbs if you have heart disease, take other QT-prolonging drugs, have electrolyte imbalances, or take doses above the recommended maximum. For someone using hydroxyzine long-term, these risk factors can accumulate, especially as you age or if new medications are added to your regimen.

The Anticholinergic Burden and Dementia

This is the concern that gets the least attention from prescribers but carries arguably the most weight for long-term users. Hydroxyzine has strong anticholinergic properties, meaning it blocks a neurotransmitter called acetylcholine that plays a central role in memory and cognition. Many medications have some anticholinergic activity, and the effects add up over time in what researchers call the anticholinergic “burden.”

A large prospective study following over 3,400 older adults for about seven years found a clear dose-response relationship between cumulative anticholinergic use and dementia risk. People with the highest cumulative exposure to strong anticholinergic medications had about a 54% higher risk of developing dementia compared to non-users, with a similar pattern for Alzheimer’s disease specifically. The risk increased in a stepwise fashion: moderate use showed a modest, non-significant bump, while the heaviest use showed the strongest and statistically significant association.

⁶

Hydroxyzine wasn’t the only anticholinergic drug in that study, but it belongs squarely in the “strong anticholinergic” category alongside drugs like diphenhydramine (Benadryl) and certain bladder medications. The key finding is that the risk is cumulative. Taking a strong anticholinergic occasionally is different from taking one daily for years. For someone using hydroxyzine every day for chronic anxiety or itching, the total exposure adds up steadily.

It’s worth noting that this was an observational study, and observational studies can’t prove causation. People who need more anticholinergic medication might differ from those who don’t in ways that independently affect dementia risk. But the dose-response pattern is concerning, and several other large studies have found similar associations. Most geriatric guidelines now specifically recommend against long-term anticholinergic use in older adults for this reason.

Older Adults Face Amplified Risks

The concerns about hydroxyzine are particularly acute for people over 65. Hydroxyzine appears on the Beers Criteria, a widely used list of medications considered potentially inappropriate for older adults. This listing is driven by the combination of sedation, anticholinergic effects, and their downstream consequences in aging bodies.

In older adults, the sedation and dizziness from hydroxyzine create a real fall risk. A study of geriatric patients in South Korea found that first-generation antihistamines including hydroxyzine were among the medications most commonly flagged for risk of adverse drug events, specifically because dizziness and drowsiness can lead to falls and fractures.

⁷

Older adults also metabolize hydroxyzine more slowly, meaning the drug stays active in their system longer and its effects are more pronounced. When you combine slower clearance with the already-long half-life, the cumulative anticholinergic burden described above, and a greater vulnerability to falls, the risk-benefit calculation for long-term hydroxyzine use in older adults tilts firmly toward risk. If you’re over 65 and have been taking hydroxyzine for months, it’s worth having a conversation with your prescriber about alternatives.

Pregnancy and Hydroxyzine

Hydroxyzine is sometimes prescribed to pregnant women for nausea, itching, or anxiety, and many people naturally wonder whether long-term prenatal exposure is safe. The evidence here is limited but not reassuring. A meta-analysis examining pregnancy outcomes in women exposed to hydroxyzine or its metabolite cetirizine found that while cetirizine alone was not associated with increased birth defect risk, a combined analysis of cetirizine and hydroxyzine studies showed a marginal association with major malformations.

⁸

“Marginal” in this context means the finding was borderline, sitting right at the edge of statistical significance. It doesn’t mean the risk is large, but it also doesn’t provide the clean bill of health you’d want from a drug used throughout pregnancy. Most obstetric guidelines now recommend second-generation antihistamines like cetirizine or loratadine over hydroxyzine during pregnancy, both because the safety data for those alternatives are stronger and because hydroxyzine’s sedation creates additional concerns during pregnancy and breastfeeding.

Children and Neurodevelopmental Concerns

Hydroxyzine is one of the most commonly prescribed medications for young children, often given for itching, sleep difficulties, or behavioral issues. A population-based longitudinal study looking at preschool-aged children prescribed hydroxyzine found a troubling pattern: children who received repeat prescriptions had higher rates of several neurodevelopmental outcomes compared to children who received only a single prescription.

⁹

Specifically, repeat prescriptions were associated with increased odds of tic disorders (about 55% higher), anxiety disorders (about 34% higher), and conduct disturbances (about 34% higher) by age 10 compared to a single prescription. There was also a non-significant trend toward higher rates of ADHD and emotional disturbances. The researchers described this as the first study to report an association between long-term hydroxyzine use and neurodevelopmental effects in young children.

⁹

This is one study, and association doesn’t equal causation. Children who get multiple prescriptions for hydroxyzine might have underlying conditions that independently increase their risk for these outcomes. But given how frequently hydroxyzine is prescribed to very young children, the findings deserve attention. At a minimum, using hydroxyzine as a chronic sleep aid or behavioral tool in preschoolers warrants caution and close monitoring.

How Hydroxyzine Stacks Up Against Alternatives

Part of evaluating whether a drug is safe for long-term use involves asking what else you could take instead. A Cochrane systematic review comparing hydroxyzine to other anxiolytic medications found that hydroxyzine was roughly equivalent to both benzodiazepines and buspirone in terms of efficacy, acceptability, and overall tolerability for generalized anxiety disorder. Where it differed was in causing more drowsiness than the comparators.

¹⁰

That equivalence is both useful and limiting. It means hydroxyzine works about as well as other options, but it also means it doesn’t offer a clear advantage that would justify accepting its additional risks. Benzodiazepines carry their own problems for long-term use, including dependence and withdrawal. But buspirone, which showed similar effectiveness to hydroxyzine in the review, doesn’t cause sedation, doesn’t have anticholinergic properties, and doesn’t carry the same cardiac or cognitive concerns. For anxiety specifically, SSRIs and SNRIs are first-line treatments with much stronger long-term safety data.

For itching and allergic conditions, second-generation antihistamines like cetirizine, loratadine, and fexofenadine are generally preferred for long-term use. They don’t cross into the brain as readily, so they cause far less sedation, and they don’t carry the same anticholinergic burden. Cetirizine is actually a metabolite of hydroxyzine, so it provides much of the same antihistamine activity with a better side-effect profile.

What “Long-Term” Actually Means for Risk

Not all long-term use carries the same weight. The dementia risk data suggest that total cumulative exposure is what matters, not just the fact that you’ve been taking the drug for a while. Someone taking 10 mg of hydroxyzine a few times a week for occasional anxiety is in a very different situation from someone taking 50 mg nightly for years. The dose, the frequency, and the total duration all multiply together.

The QT prolongation risk similarly scales with dose and with the number of other risk factors present. At standard doses in an otherwise healthy person, the cardiac risk is vanishingly small. At higher doses, or when combined with other medications or heart conditions, it becomes more meaningful.

This means the answer to “is hydroxyzine safe for long-term use” isn’t a flat yes or no. A low dose used intermittently for a condition that genuinely needs it, with periodic reassessment, is a very different proposition from a high dose used daily on autopilot because nobody revisited the prescription. If you’ve been on hydroxyzine for more than a few months, the most useful thing you can do is ask your prescriber two questions: is this still the best option for what I’m treating, and have any new risk factors appeared since I started it?

The Dry Mouth and Other Anticholinergic Side Effects

Beyond the headline risks of dementia and sedation, the anticholinergic effects of hydroxyzine produce a collection of everyday side effects that compound with long-term use. Dry mouth is the most common and the most underestimated. It sounds minor, but chronic dry mouth significantly increases the risk of dental cavities, gum disease, and oral infections because saliva is your mouth’s primary defense against bacteria. People who take anticholinergic drugs for years often develop dental problems that seem unrelated to their medication but are a direct consequence of it.

Constipation, blurred vision, and urinary retention round out the typical anticholinergic side-effect profile. These are manageable individually, but together they form a pattern of low-grade physical nuisance that can erode quality of life over time. In the 12-week pruritus study, these effects were described as mild and self-resolving, but 12 weeks of mild dry mouth is different from two years of it.

²

For people who do stay on hydroxyzine long-term, proactive management of these side effects matters. Extra attention to oral hygiene, adequate hydration, and regular dental visits can mitigate the dry-mouth problem. Monitoring for constipation and adjusting diet or adding fiber can prevent what starts as an annoyance from becoming a medical issue. These aren’t dramatic interventions, but they’re the kind of practical steps that make a real difference when the medication isn’t going away anytime soon.